Chaperone therapy for mucopolysaccharidosis type IIIC

被引：1
|
作者：
Pshezhetsky, Alexey V. [1 ]
Pan, Xuefang [1 ]
Heon-Roberts, Rachel [1 ]
Li, Shao-Gang [2 ]
Wu, Harry Y. [1 ]
Taherzadeh, Mahsa [1 ]
De Aragao, Camila De Britto Para [1 ]
Wood, Jill [3 ]
Ekins, Sean [3 ]
Boyd, Robert [3 ]
Freundlich, Joel S. [2 ]
机构：
[1] Univ Montreal, CHU Ste Justine, Montreal, PQ, Canada
[2] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA
[3] Phoenix Nest Inc, New York, NY USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2018年 / 123卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2017.12.329
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
320
引用
收藏
页码：S121 / S122
页数：2
相关论文
共 50 条
  • [31] Enzyme replacement therapy in mucopolysaccharidosis type II
    Castorina, M.
    Antuzzi, D.
    Zampetti, A.
    Ricci, R.
    ACTA PAEDIATRICA, 2008, 97 : 101 - 101
  • [32] Immortalisation of a mucopolysaccharidosis type IIIC fibroblast cell line via expression of SV40 T antigen
    Nelson, K
    Melville, EL
    Meikle, PJ
    Anson, DS
    CELL BIOLOGY INTERNATIONAL, 2003, 27 (07) : 567 - 570
  • [33] Bromocriptine as a Novel Pharmacological Chaperone for Mucopolysaccharidosis IV A
    Olarte-Avellaneda, Sergio
    Cepeda Del Castillo, Jacobo
    Felipe Rojas-Rodriguez, Andres
    Sanchez, Oscar
    Rodriguez-Lopez, Alexander
    Suarez Garcia, Diego A.
    Salazar Pulido, Luz Mary
    Almeciga-Diaz, Carlos J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (07): : 1377 - 1385
  • [34] Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC
    O'Leary, Claire
    Forte, Gabriella
    Mitchell, Nadia L.
    Youshani, Amir Saam
    Dyer, Adam
    Wellby, Martin P.
    Russell, Katharina N.
    Murray, Samantha J.
    Jolinon, Nelly
    Jones, Simon A.
    Stacey, Kevin
    Davis, Daniel M.
    Henckaerts, Els
    Palmer, David N.
    Kamaly-Asl, Ian
    Bigger, Brian W.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [35] Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC
    Claire O’Leary
    Gabriella Forte
    Nadia L. Mitchell
    Amir Saam Youshani
    Adam Dyer
    Martin P. Wellby
    Katharina N. Russell
    Samantha J. Murray
    Nelly Jolinon
    Simon A Jones
    Kevin Stacey
    Daniel M. Davis
    Els Henckaerts
    David N. Palmer
    Ian Kamaly-Asl
    Brian W. Bigger
    Journal of Translational Medicine, 21
  • [36] Enzyme replacement therapy for mucopolysaccharidosis type I in Japan
    Okuyama, T.
    Tanaka, T.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 119 - 119
  • [37] Postenzyme replacement therapy era for type 2 mucopolysaccharidosis
    Chou, Wei-Chih
    Weng, Chun-Ying
    Lin, Shuan-Pei
    Chu, Shao-Yin
    TZU CHI MEDICAL JOURNAL, 2013, 25 (02): : 128 - 129
  • [38] An adenoviral mediated gene therapy for mucopolysaccharidosis type I
    Hurt, Sarah
    Le, Steven Q.
    Mendonca, Samir
    Dickson, Patricia
    Curiel, David T.
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S60 - S60
  • [39] Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI
    Brunelli, Marcela Junqueira
    Atallah, Alvaro N.
    da Silva, Edina M. K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (09):
  • [40] Update on enzyme replacement therapy in mucopolysaccharidosis type II
    Muenzer, J
    Scarpa, M
    ACTA PAEDIATRICA, 2002, 91 : 81 - 81
12345